| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9748 | 
      | Human Intestinal Absorption | HIA- | 0.9520 | 
      | Caco-2 Permeability | Caco2- | 0.8957 | 
      | P-glycoprotein Substrate | Substrate | 0.7260 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8942 | 
                                                     | Inhibitor | 0.5293 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8024 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.4446 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7943 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8172 | 
      | CYP450 3A4 Substrate | Substrate | 0.5374 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.7538 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.7088 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.8666 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.7034 | 
      | CYP450 3A4 Inhibitor | Inhibitor | 0.6432 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5509 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9865 | 
                                                                    | Non-inhibitor | 0.6145 | 
      | AMES Toxicity | Non AMES toxic | 0.7336 | 
      | Carcinogens | Non-carcinogens | 0.8392 | 
      | Fish Toxicity | High FHMT | 0.9909 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9415 | 
      | Honey Bee Toxicity | Low HBT | 0.6704 | 
      | Biodegradation | Not ready biodegradable | 0.9968 | 
      | Acute Oral Toxicity | III | 0.4938 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5045 |